Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $6.77, but opened at $7.25. Lumexa Imaging shares last traded at $7.2710, with a volume of 465,230 shares.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on LMRI shares. Raymond James Financial raised Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective for the company in a research report on Monday, February 9th. Weiss Ratings started coverage on Lumexa Imaging in a research report on Wednesday, May 13th. They set a “sell (e-)” rating for the company. Finally, Barclays lowered their price objective on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.
Read Our Latest Analysis on LMRI
Lumexa Imaging Price Performance
Institutional Trading of Lumexa Imaging
Large investors have recently made changes to their positions in the company. Readystate Asset Management LP lifted its position in Lumexa Imaging by 60.5% during the 1st quarter. Readystate Asset Management LP now owns 224,755 shares of the company’s stock worth $1,933,000 after acquiring an additional 84,755 shares during the period. Sei Investments Co. lifted its position in Lumexa Imaging by 339.6% during the 1st quarter. Sei Investments Co. now owns 88,190 shares of the company’s stock worth $758,000 after acquiring an additional 68,127 shares during the period. State of Wyoming acquired a new stake in Lumexa Imaging during the 1st quarter worth approximately $91,000. PNC Financial Services Group Inc. acquired a new stake in Lumexa Imaging during the 1st quarter worth approximately $63,000. Finally, Emerald Mutual Fund Advisers Trust lifted its position in Lumexa Imaging by 11.0% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 653,342 shares of the company’s stock worth $5,619,000 after acquiring an additional 64,677 shares during the period.
About Lumexa Imaging
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Read More
- Five stocks we like better than Lumexa Imaging
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
